￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Fenelidone (Keshenda) dosage adjustment principles and individualized medication recommendations

2026-02-01 22:25:32

Check Details
Rasagiline (Alzilate) drug safety analysis and long-term use risk assessment

2026-02-01 22:25:32

Check Details
Analysis of the effectiveness of platinib (Pujihua) in patients with RET fusion mutations

2026-02-01 22:25:32

Check Details
Clinical trials related to new indications of capmatinib (Touradida) and future prospects

2026-02-01 22:25:32

Check Details
Is it better to take Sotolaxib (AMG 510) before or after meals for better absorption?

2026-02-01 22:25:32

Check Details
What is the medical insurance coverage rate in Adagrasib (Krazati) and analysis of policy differences in different provinces

2026-02-01 22:25:32

Check Details
Will larotrectinib (Vitaika) affect the safety of other medications for patients with chronic diseases?

2026-02-01 22:25:32

Check Details
Will selinesol (silvio) cause insomnia to worsen during treatment and how to deal with it

2026-02-01 22:25:32

Check Details
Analysis on the price of Indian version of Vigabatrin and its difference with the original drug

2026-02-01 22:25:32

Check Details
Analysis of the potential of moboxetinib (Anvili) to treat other types of cancer

2026-02-01 22:25:32

Check Details
Comparison of the efficacy of Tepotinib (Tuodekang) and Crizotinib and analysis of applicable patients

2026-02-01 22:25:32

Check Details
Can regorafenib (Belvango) effectively shrink tumors and clinical case analysis

2026-02-01 22:25:32

Check Details
Category
相关知识